Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leslie M Randall

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Future Oncology (London, England)|September 4, 2020
Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancerB J Rimel, Lauren Dockery, Leslie M Randall, et al.
Expert Review of Molecular Diagnostics|February 8, 2020
A profile on the FoundationFocus CDxBRCA testsLindsey Ford, Juliet E Wolford, Sandra M Brown, et al.
Gynecologic Oncology Reports|April 1, 2022
Cervical cancer - times… they are a changing: A report from the Society of Gynecologic Oncology journal clubChristine S Walsh, Charles A Leath, Jyoti Mayadev, et al.
Gynecologic Oncology|December 24, 2013
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage diseaseRobert E Bristow, Jenny Chang, Argyrios Ziogas, et al.
The Journal of Obstetrics and Gynaecology Research|May 1, 2012
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell lineRamez N Eskander, Leslie M Randall, Toshinori Sakai, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Expanding Our Impact in Cervical Cancer Treatment: Novel Immunotherapies, Radiation Innovations, and Consideration of Rare HistologiesLeslie M Randall, Amanda J Walker, Angela Y Jia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 25, 2013
Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell linesRamez N Eskander, Tao Ji, Be Huynh, et al.
Gynecologic Oncology|August 1, 2019
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancerLeslie M Randall, Robert M Wenham, Philip S Low, et al.
Military Medicine|June 5, 2020
Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military PopulationSteffanie Owens, Tara Blando, Yohannes B Tesema, et al.
Gynecologic Oncology|September 26, 2018
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancerOliver Zivanovic, Dennis S Chi, Olga Filippova, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Future Oncology (London, England)|September 4, 2020
Niraparib in the treatment of previously treated advanced ovarian, fallopian tube or primary peritoneal cancerB J Rimel, Lauren Dockery, Leslie M Randall, et al.
Expert Review of Molecular Diagnostics|February 8, 2020
A profile on the FoundationFocus CDxBRCA testsLindsey Ford, Juliet E Wolford, Sandra M Brown, et al.
Gynecologic Oncology Reports|April 1, 2022
Cervical cancer - times… they are a changing: A report from the Society of Gynecologic Oncology journal clubChristine S Walsh, Charles A Leath, Jyoti Mayadev, et al.
Gynecologic Oncology|December 24, 2013
High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage diseaseRobert E Bristow, Jenny Chang, Argyrios Ziogas, et al.
The Journal of Obstetrics and Gynaecology Research|May 1, 2012
Flavokawain B, a novel, naturally occurring chalcone, exhibits robust apoptotic effects and induces G2/M arrest of a uterine leiomyosarcoma cell lineRamez N Eskander, Leslie M Randall, Toshinori Sakai, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 19, 2021
Expanding Our Impact in Cervical Cancer Treatment: Novel Immunotherapies, Radiation Innovations, and Consideration of Rare HistologiesLeslie M Randall, Amanda J Walker, Angela Y Jia, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 25, 2013
Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell linesRamez N Eskander, Tao Ji, Be Huynh, et al.
Gynecologic Oncology|August 1, 2019
A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancerLeslie M Randall, Robert M Wenham, Philip S Low, et al.
Military Medicine|June 5, 2020
Incidence Rates of Gynecologic Cancers in the U.S. Active Duty Military PopulationSteffanie Owens, Tara Blando, Yohannes B Tesema, et al.
Gynecologic Oncology|September 26, 2018
It's time to warm up to hyperthermic intraperitoneal chemotherapy for patients with ovarian cancerOliver Zivanovic, Dennis S Chi, Olga Filippova, et al.
Pageof 6